COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR and Serum Institute of India
The ICMR funded the clinical trial site fees while the SII provided the other expenses for the vaccine, said a release.
Full Article
COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR and Serum Institute of India
Hindu
0 shares
1 views
You might like
Related news coverage
Volunteer seeks investigation on Serum after developing complication but company is intimidating
Mid-Day
The 40-year old volunteer, who works as a business consultant had wanted to investigate the cause of him contracting severe..
-
Bharat Biotech's COVID-19 vaccine 'Covaxin' commences phase-3 trial at AIIMS
Mid-Day
-
Centre to electronically track details of COVID-19 vaccine recipients: Harsh Vardhan
Mid-Day
-
Centre to electronically track details of COVID-19 vaccine recipients: Health Minister
Mid-Day
-
Bharat Biotech starts phase III trials for COVAXIN
Mid-Day
Advertisement
More coverage
Third phase trials of COVID-19 vaccine Covaxin begin
Mid-Day
Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-3 trials of Covaxin, India's first indigenous vaccine..